Smith ScholarWorks
Exercise and Sport Studies: Faculty
Publications

Exercise and Sport Studies

1-1-2010

Relationship Between Circulating Progenitor Cells, Vascular
Function and Oxidative Stress with Long-Term Training and ShortTerm Detraining in Older Men
Sarah Witkowski
University of Maryland School of Public Health, switkowski@smith.edu

Michael M. Lockard
University of Maryland School of Public Health

Nathan T. Jenkins
University of Maryland School of Public Health

Thomas O. Obisesan
University of Maryland School of Public Health

Espen E. Spangenburg
University of Maryland School of Public Health

See next page for additional authors
Follow this and additional works at: https://scholarworks.smith.edu/ess_facpubs
Part of the Exercise Science Commons, and the Sports Studies Commons

Recommended Citation
Witkowski, Sarah; Lockard, Michael M.; Jenkins, Nathan T.; Obisesan, Thomas O.; Spangenburg, Espen E.;
and Hagberg, James M., "Relationship Between Circulating Progenitor Cells, Vascular Function and
Oxidative Stress with Long-Term Training and Short-Term Detraining in Older Men" (2010). Exercise and
Sport Studies: Faculty Publications, Smith College, Northampton, MA.
https://scholarworks.smith.edu/ess_facpubs/24

This Article has been accepted for inclusion in Exercise and Sport Studies: Faculty Publications by an authorized
administrator of Smith ScholarWorks. For more information, please contact scholarworks@smith.edu

Authors
Sarah Witkowski, Michael M. Lockard, Nathan T. Jenkins, Thomas O. Obisesan, Espen E. Spangenburg,
and James M. Hagberg

This article is available at Smith ScholarWorks: https://scholarworks.smith.edu/ess_facpubs/24

NIH Public Access
Author Manuscript
Clin Sci (Lond). Author manuscript; available in PMC 2011 August 24.

NIH-PA Author Manuscript

Published in final edited form as:
Clin Sci (Lond). 2010 February ; 118(4): 303–311. doi:10.1042/CS20090253.

Relationship between circulating progenitor cells, vascular
function and oxidative stress with long-term training and shortterm detraining in older men
Sarah WITKOWSKI, Michael M. LOCKARD, Nathan T. JENKINS, Thomas O. OBISESAN,
Espen E. SPANGENBURG, and James M. HAGBERG
Department of Kinesiology, University of Maryland College Park School of Public Health, College
Park, MD 20742, U.S.A

Abstract
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Exercise may contribute to the maintenance of vascular function via enhanced liberation and
action of bone-marrow-derived progenitor cells. Activity related changes in oxidative stress may
also influence the number and function of these cells. In the present study, we sought to determine
(i) whether adaptations in reactive hyperaemic FBF (forearm blood flow) response associated with
long-term endurance exercise and short-term detraining were related to resting putative progenitor
cell number and function, and (ii) whether oxidative stress affected these factors. Participants
included men with a history of more than 30 years of moderate-to-high-intensity exercise (HI
group) and healthy low-active age- and BMI (body mass index)-matched control subjects (LO
group). Vascular reactive hyperaemic FBF response, resting CD34+ and CD34+/VEGFR2+
(vascular endothelial growth factor receptor 2+] cell number, CFU-EC (colony-forming unitendothelial cell) count and CFU-EC senescence were evaluated. Oxidative stress measures
included OxLDL (oxidized low-density lipoprotein) and TAC (total antioxidant capacity). These
measures were assessed following 10 days of detraining in the HI group. The HI group had greater
peak reactive hyperaemic FBF responses compared with the LO group, despite no difference in
resting CD34+ cell number, CD34+/VEGFR2+ cell number, CFU-EC colonies or CFU-EC
senescence. With detraining in the HI group, CD34+ cells declined 44 %, and the percentage
change in CD34+/VEGFR2+ cells was positively correlated with the change in FBF response to
reactive hyperaemia. The percentage change in CD34+/VEGFR2+ cells and the percentage change
in EPC (endothelial progenitor cell) senescence with detraining were related to the percentage
change in TAC. These results reveal that changes in reactive hyperaemic FBF are closely related
to activity dependent dynamic changes in CD34+/VEGFR2+ cell number, which may be
influenced by alterations in oxidative stress.
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INTRODUCTION
Disruption of vascular endothelial integrity and function is a major contributor to the
development of atherosclerosis and CVD (cardiovascular disease) [1]. Circulating HPCs
(haemapoietic progenitor cells) and EPCs (endothelial progenitor cells) may play an
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important role in the maintenance of vascular integrity [2,3]. Reduced EPC number and
function have been associated with death from CVD [4], CVD risk factors [5], future
coronary events [6] and endothelial dysfunction [7].
Physical activity is associated with improved endothelial health and vascular function [8–
10]. In general, an acute bout of exercise increases the number of EPCs in the blood in
healthy individuals and in patients with CVD or CVD risk factors [11,12]. Endurance
exercise training has been associated with improved EPC clonogenic and migratory
capacities in healthy men [13]. Short-term exercise training (4–12 weeks) has also been
associated with increased circulating EPCs in patients with CAD (coronary artery disease)
[14], CAD risk factors [15] and chronic heart failure [16], but not in healthy young and older
men [17]. Therefore it is well documented that short-term exercise training increases resting
EPC number and function in patients with CVD; however, it remains unclear what effect
long-term exercise training has on EPCs in healthy individuals.
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EPCs are sensitive to changes in redox potential and have a high expression of the
antioxidant enzymes catalase, glutathione peroxidase and MnSOD (manganese superoxide)
[18,19]. Disruptions in redox state can detrimentally affect EPC function [20]. In vitro
evidence indicates that the highly atherogenic oxLDL [oxidized LDL (low-density
lipoprotein)] decreased EPC number, proliferative capacity, migration, adhesion [21] and
senescence [22]. Exercise training influences oxidative stress and antioxidant capacity
[23,24]. Therefore it is possible that changes in oxidative stress status that occur with
changes in physical activity status could influence circulating EPC number and/or function.
The aim of the present study was to investigate the influence of long-term endurance
exercise training on the association of CD34+ cells, CD34+/VEGFR2+ [VEGF (vascular
endothelial growth factor) receptor 2+] cells, CFU-EC (colony-forming unit-endothelial cell)
count, and CFU-EC senescence with reactive hyperaemic FBF (forearm blood flow)
response. To achieve this purpose, we studied healthy highly active men with a long-term
physical activity history (HI group) and low-active sedentary but healthy men (LO group).
In addition, through the use of short-term detraining, we sought to evaluate the influence of
changes in physical activity state in the HI group on the reactive hyperaemic FBF response
and EPCs. Finally, we investigated differences in markers of oxidative stress, antioxidant
capacity and NO bioavailability as potential contributors to changes observed in EPCs.

MATERIALS AND METHODS
Participants

NIH-PA Author Manuscript

Written informed consent was obtained from all subjects, and the study was approved by the
University of Maryland College Park Institutional Review Board. A total of 12 healthy longterm endurance-trained men (HI group) and 11 healthy age- and BMI (body mass index)matched sedentary men (LO group) participated in the study. To verify physical activity
status for inclusion, all participants completed a physical activity questionnaire. The LO
group did not participate in or have a recent history of moderate-to-intense regular
endurance exercise (< 2 days/week; 20 min/session). Ten of the HI group participated in 10
days of detraining following baseline testing. Physical examination, resting BP (blood
pressure), blood chemistry and screening for CVD via a 12-lead ECG stress test were
performed to verify study eligibility. Participants were non-smokers and were not taking
medication that has been demonstrated to affect EPC number and/or function [25].
Participants were tested following an overnight fast, 24 h without alcohol and caffeine and
48 h without vitamins or medication prior to testing.
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Participants underwent treadmill V̇O2max [maximal V̇O2 (oxygen consumption)] testing,
assessment of reactive hyperaemia, venipuncture for blood samples and body composition
testing. Testing of men in the HI group occurred 24 h after the last exercise session to
eliminate the acute effects of physical activity. The men in the HI group who volunteered for
detraining (n = 10) returned following the 10 days for repeated measures of reactive
hyperaemic FBF response, blood-derived parameters and body composition. Those
participating in detraining were instructed to maintain a stable weight for the 10 days of
training cessation and recorded morning and evening weight in a data log. FBF and NO
testing occurred following 3 days of a low-nitrate diet [26].
V̇O2max—Treadmill V̇O2max testing was performed under physician supervision. Heart rate,
ECG and BP were monitored throughout the test. Expired air was sampled using indirect
calorimetry (Oxycon Pro; Viasys). Treadmill testing was a modification of the Bruce
protocol where treadmill speed was determined by the investigator based on heart rate such
that V̇O2max was achieved between 8 and 12 min. For all of the tests, three out of four
criteria were met for a valid V̇O2max: RER (respiratory exchange reserve) ≥1.15, maximal
heart rate (age-predicted) was reached, a plateau in the V̇O2 increase with an increase in
work rate (< 250 ml V̇O2 increase) was observed, or the subject indicated exhaustion.
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FBF response to reactive hyperaemia—FBF was evaluated in the non-dominant arm
with strain gauge plethysmography at baseline and during reactive hyperaemia as described
previously in our laboratory [27]. Briefly, basal FBF was measured in triplicate. Forearm
ischaemia was achieved by a 5-min occlusion with the upper-arm pressure cuff inflated to a
pressure that was 50 mmHg above the participant’s resting systolic BP. Following forearm
ischaemia, FBF was measured every 15 s continuously (measurement for 7 s and rest for 8 s)
for 3 min. Reactive hyperaemic measures included peak FBF and minimum FVR (forearm
vascular resistance; mmHg · ml−1 · min−1 · 100 ml−1 of tissue). As the maximal hyperaemic
response has been demonstrated to occur within 1 min of occlusion release [28], the AUC
(area under the curve) for the 1 min of the hyperaemic response (AUC1min in ml/100 ml)
was calculated according to the trapezoidal rule.
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Circulating progenitor cell number—CD34+ (HPC) and CD34+/VEGFR2+ (putative
EPC) number were determined by flow cytometry. PBMCs (peripheral blood mononuclear
cells) were separated via density centrifugation (Ficoll–Paque Plus; GE Healthcare). A total
of 1× 106 mononuclear cells were immunostained with FITC-conjugated monoclonal
antibodies specific for human CD34 (BD Biosciences) and PE (phycoerytherin)-conjugated
monoclonal antibodies specific for human VEGFR2 (R&D Systems). At least 5×105 cells
were labelled with appropriate controls for isotype and positive antibodies. All cells were
FcR-blocked (Miltenyi Biotech) and fixed in 4 % paraformaldehyde. Flow cytometry was
performed in the Flow Cytometry/Cell Sorting CORE Laboratory with a Beckman Coulter
Epics Elite ESP flow cytometer and cell sorter. The forward-side-scatter plot was used to
identify the lymphocyte gate. A total of 100 000 events per sample were acquired.
Reproducibility was tested with a subset of samples (r = 0.90, P < 0.001).
CFU-EC count—The CFU-EC assay was performed with the EndoCult Liquid Medium
Kit (Stem Cell Technologies), according to the manufacturer’s specifications. Colonies were
counted after 5 days of culture by two independent observers to address reproducibility (r =
0.98, P < 0.001). A colony was defined as a central core of round cells with more elongated
sprouting cells at the periphery. The endothelial lineage of these cells has been confirmed
previously via immunocytochemical staining for vWF (von Willebrand factor), VEGFR2
and CD31 [7].
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CFU-EC senescence—Cellular senescence is an indicator of exhaustion of the
replicative potential of a cell [29], and higher EPC senescence has been related to increased
CVD risk [7]. CFU-EC senescence was determined using a β-gal (β-galactosidase) Cellular
Senescence assay kit (Chemicon International). After CFU-EC enumeration on day 5, the
culture medium was changed and cells were incubated for an additional 2 days. On day 7,
cells were fixed and SA-β-gal (senescence-associated β-gal) stain solution was added to the
wells. Cells distant from central colonies from four randomly selected fields that contained
100–200 cells each were analysed. β-Gal-positive cells were counted as senescent, and
senescence was quantified by the average percentage of β-gal-positive cells in each of the
four wells.
NOx (nitrate/nitrite) assay—Plasma was filtered via centrifugation with 10 kDa cut-off
centrifugal ultrafilters (Millipore Corporation) at 9000 g and 4°C for 50 min. NOx
concentration of the filtered plasma was analysed via a modification of the Griess reaction,
as described previously [30]. Absorbance was read at 541 nm (Emax; Molecular Devices).
Samples were assayed in duplicate. Inter- and intra-assay CVs (coefficients of variation)
were 9.9 and 3.4 % respectively.
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Plasma OxLDL—Plasma OxLDL levels were measured using a commercially available
competitive ELISA kit (Mercodia) as described previously [31]. Two-level control samples
(Mercodia Oxidized LDL Control Kit) were assayed to confirm assay performance. All
samples were analysed in a single assay to eliminate inter-assay variability. The intra-assay
CV was 6.8 %.
TAC (total antioxidant capacity)—TAC (aqueous and lipid-soluble antioxidants,
including vitamins, proteins, lipids, glutathione and uric acid) in plasma was analysed in
duplicate using a commercial kit (Cayman Chemical) developed from the protocol described
by Miller and Rice-Evans [32]. All samples were analysed in a single assay to eliminate
inter-assay variability. The intra-assay CV was 4.1 %.
Body composition—Height and weight were recorded and BMI (kg/m2) was calculated
for all subjects. To quantify the percentages of lean and fat mass, body composition was
assessed via dual-energy X-ray absorptiometry (Discovery A, software version 12.7.1;
Hologic).
Framingham CHD (coronary heart disease) risk—To assess conventional CHD risk
factors, risk scores for CHD were calculated based on equations from the Framingham study
[33].
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Statistical analysis
Sample size (β = 0.8, α= 0.05) for the study was calculated a priori based on effect size
estimates from findings published in the literature for changes in CD34+/VEGFR2+ cells
[12,14], CFU-EC colony number [12,14], CFU-EC senescence [7] and FBF with exercise
training [34]. Student’s t tests were used to test for differences between the HI and LO
groups. Where data were not normally distributed, the non-parametric Mann–Whitney U test
(Wilcoxon rank-sum test) was used to compare differences between groups. Paired
Student’s t tests were used to examine differences between the HI group before and after
detraining. Where paired data were not normally distributed, the non-parametric Wilcoxon
signed-rank test was used to compare athletes before and after detraining. Differences
between groups for the reactive hyperaemic FBF response were tested using a repeated
measures ANOVA. Correlation coefficients were used to examine the relationships between
variables. Multiple regression analysis was used to determine the predictors of CD34+/
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VEGFR2+ cells, CFU-EC colony number and CFU-EC senescence. Data transformation was
performed to satisfy test assumptions where appropriate. An α level of 0.05 was used to
indicate statistical significance.

RESULTS
Participant characteristics
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Groups were successfully matched for age and BMI (Table 1). Running was the
predominant physical activity mode in the HI group, as all 12 HI participants engaged in
running with an average of 5 ± 0.4 days/week. Six of the 12 HI participants also reported
cycling, ranging from occasionally to 3 days/week. Swimming was reported in three of the
HI group, ranging from occasionally to 3 days/week. Other modes of exercise (i.e. weights
and rowing) were reported in three HI participants (range of 1 to 3 days/week). The HI
group had a significantly and substantially higher V̇O2max than the LO participants. Body
weight and BMI did not change in the men in the HI group who participated in the 10-day
detraining (Table 1); however the percentage body fat was significantly (P < 0.001) greater
after detraining (Table 1). Compared with the LO participants, the HI group had lower body
fat and diastolic BP, and a better blood chemistry profile, including lower plasma
triacylglycerols (triglycerides), higher HDL (high-density lipoprotein)-cholesterol and lower
VLDL (very-low-density lipoprotein)-cholesterol; importantly, none of these factors
correlated with the main outcome variables of reactive hyperaemic FBF response, CD34+
cell number, CD34+/VEGFR2+ cell number, CFU-EC number or CFU-EC senescence.
Resting TAC was significantly lower in the HI group compared with the LO group (2.25 ±
0.05 compared with 2.54 ± 0.06 mmol/l; P = 0.002). There were no differences in OxLDL
and NOx between the groups.
Reactive hyperaemic FBF
Resting FBF ranged from 0.95 to 3.23 ml · min−1 · 100 ml−1 of tissue and was not different
between the HI and LO groups (Figure 1). Following cuff occlusion, FBF increased
significantly in the HI (P < 0.001) and LO (P < 0.001) groups (838 ± 90 and 609 ± 74 %
respectively). Peak FBF was significantly greater in the HI group compared with the LO
group (P = 0.03), which corresponded to a lower minimum FVR in this group (P = 0.03).
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There were no significant changes in any of the FBF measurements in the HI group
following the 10 days of detraining. However, peak FBF remained significantly higher and
minimum FVR remained significantly lower in the HI group after detraining compared with
the LO group [19 ± 2 compared with 13± 1 ml · min−1 · 100 ml−1 (P = 0.005) and 5 ± 1
compared with 7 ± 1 mmHg · ml−1 · min−1 · 100 ml−1 (P = 0.004) respectively].
Progenitor cells
When the HI and LO groups were combined, the CFU-EC count was negatively correlated
with the Framingham risk percentage (r = −0.49, P = 0.02). In addition, regression analysis
indicated that circulating OxLDL levels significantly predicted CFU-EC colonies (P = 0.03)
when the groups were combined. However, CD34+ cells (447 ± 143 compared with 341 ±
140 cells/100 000 events; P = 0.26), CD34+/VEGFR2+ cells (99 ± 39 compared with 43 ±
13 cells/100 000 events; P = 0.23), CFU-EC colonies (18 ± 4 compared with 14± 4; P =
0.26) and CFU-EC senescence (23.4 ± 3.7 compared with 22.6 ± 5.1 %; P = 0.45) at rest
were not different between the HI and LO groups.
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As shown in Figure 2, HPCs significantly declined by 44 % in the HI group following 10
days of detraining (322 ± 91 compared with 179 ± 37 cells/100 000 events; P = 0.03).
CD34+/VEGFR2+ cell number (Figure 3), CFU-EC colonies and CFU-EC senescence
tended to decrease with detraining, although the declines were not significant [89 ± 44 vs. 16
± 7 cells/100 000 events (P = 0.13); 18 ± 4 compared with 12 ± 4 colonies (P = 0.34); and
23 ± 3 compared with 16 ± 3 % (P = 0.11) respectively]. Overall, the percentage change in
the CD34+/VEGFR2+ cell number correlated significantly with baseline CD34+/VEGFR2+
cell number (r = −0.76, P = 0.01) in the ten HI participants who discontinued training.
In the HI participants who underwent detraining, the percentage change in CD34+/
VEGFR2+ cells from before to after the 10 days was significantly correlated with the
percentage change in AUC1min in response to reactive hyperaemia (r = 0.70, P = 0.02). In
the regression analysis, the percentage change in the AUC significantly predicted the change
in CD34+/VEGFR2+ number with detraining (P = 0.02). In addition, the percentage change
in CFU-EC senescence with detraining was significantly related to the percentage change in
TAC from before to after detraining (r = −0.66, P = 0.04). There was a trend for a
relationship between the percentage change in CD34+/VEGFR2+ cell number and
percentage change in TAC (r = 0.62, P = 0.056).
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DISCUSSION
The results of the present study provide evidence that circulating CD34+/VEGFR2+ cells at
rest are associated with dynamic changes in vascular reactivity with short-term detraining,
but not with vascular adaptations resulting from long-term exercise training in men.
Furthermore, changes in putative EPC number and senescence with short-term detraining
may be influenced by plasma antioxidant capacity.
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Previous studies have indicated that an acute exercise bout increases circulating bonemarrow-derived endothelial-targeted cells in the blood [11,12]; however, results from
studies evaluating resting EPC number following exercise training in humans are not
consistent. Specifically, groups have reported that exercise training improves resting CD34+/
VEGFR2+ cells in patients with CAD [14] and chronic heart failure [16] and CD34+/
VEGFR2+/CD133+ cells in patients with CAD and CAD risk factors [15], but not in healthy
young and older men [17] trained for 8 weeks. Our present results revealed no difference in
CD34+ or CD34+/VEGFR2+ cells at rest between our sedentary control and athlete groups,
who had dramatically different life-long exercise habits. It appears that exercise training,
either short-term (8 weeks [17]) or long-term (>30 years in our present study), does not
affect resting CD34+/VEGFR2+ cells in healthy individuals, whereas exercise training may
increase resting circulating EPCs in individuals with CVD and, therefore, endothelial
damage. Laufs et al. [14] reported a 75 % increase in CD34+/VEGFR2+ cells with 28 days
of training (from 23 ± 7 to 40 ± 12 CD34+/VEGFR2+ cells/100 000 events) in patients with
stable CAD. Notably, CD34+/VEGFR2+ cells before training in this population were lower
than those of our healthy sedentary participants and our sedentary group had greater CD34+/
VEGFR2+ cell number at rest (43 ± 14 cells/100 000 events) than the CAD patient
population had following exercise training [14]. Therefore the similarity in CD34+/
VEGFR2+ cell number between athletes and low-active sedentary participants may have
been because our control group was disease-free.
In the HI group, we found that CD34+ cells decreased following 10 days with no exercise.
CD34+ cells have been negatively correlated with CVD risk [35] and independently
predicted cardiovascular events, total events and death [36]. Additionally, a low CD34+
count was reported to significantly increase adverse outcome risk in patients with the
Clin Sci (Lond). Author manuscript; available in PMC 2011 August 24.

WITKOWSKI et al.

Page 7

NIH-PA Author Manuscript

metabolic syndrome [36]. There is little information regarding resting CD34+ cells and
exercise; specifically, these bone-marrow-derived HPCs have been found to be both higher
at rest in middle-aged runners compared with sedentary controls [37] and not different in
older trained men compared with older untrained men [17]. To our knowledge, the present
study is the first to report a decrease in these cells in long-term trained runners following a
cessation of exercise.
In an important finding, the detraining-induced changes in CD34+/VEGFR2+ cells were
significantly correlated with changes in forearm vascular response to reactive hyperaemia.
The relationship between EPC number and vascular function has been shown in the
coronary vasculature in patients with CAD [38], but not with respect to short-term dynamic
changes in the peripheral vasculature in healthy individuals. The role of EPCs in the
vasculature has been investigated for over 10 years; however, there are few in vivo results
showing a relationship between the number of CD34+/VEGFR2+ cells in the circulation and
a vascular functional measure. The present study is the first report of a relationship between
these cells with both reactive hyperaemic FBF response and Framingham risk score,
supporting further the role of these cells in the maintenance of a healthy vasculature.
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Relatively short-term detraining (10 days) in the HI group revealed a large degree of
individual variability in the change in CD34+/VEGFR2+ cell number. The literature to date
on changes in CD34+/VEGFR2+ EPCs with acute exercise and training also has revealed a
significant degree of individual variability [12,14,17]. In our present analysis, we found that
the change in CD34+/VEGFR2+ cell number with detraining ranged from −99 to 142 %. In
fact, the response to exercise of most health-related phenotypes is typified by individuals
that have differing grades of response [39]. It is possible that individual differences in
changes in EPCs with detraining could be the result of uninvestigated physiological factors
or genetic influences, although further studies are necessary to confirm this speculation.
In our present study, we observed relationships between oxidative stress variables and EPCs.
Oxidative stress represents the balance between the pro- and anti-oxidant forces in a system
and may play a role in vascular integrity and function. Elevated plasma OxLDL levels
promote atherosclerosis [40], have been shown in patients with CAD and predict future
cardiovascular events in these patients [41]. OxLDL decreases EPC clonogenic capacity
[42], increases EPC senescence [22] and decreases VEGF-stimulated differentiation of
cultured EPCs [43]. We found that plasma OxLDL was a significant predictor of CFU-EC
colony number, independent of physical activity status. To our knowledge, the present study
is the first to report in vivo evidence that plasma OxLDL is significantly related to CFU-EC
colonies in healthy individuals.
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EPCs have been shown to exhibit a high expression of antioxidant enzymes such as catalase,
MnSOD and glutathione peroxidase [18,19], which may be necessary for survival in
oxidative-stress-rich vascular regions damaged by atherosclerosis. In vitro evidence has
shown that incubation of EPCs with vitamins C and E had positive effects on EPC number
[44]. To date, there is little in vivo evidence supporting this relationship. Our present
analyses showed that, with detraining, increased TAC was related to increased circulating
CD34+/VEGFR2+ cells and there was a trend for a relationship between decreased TAC and
greater CFU-EC senescence. These findings support the relationship between dynamic
changes in oxidative stress and EPCs with detraining. Intense exercise training decreases
circulating antioxidants [24] and 10 days of physical inactivity may have allowed TAC to
recover in some athletes. Although these results are intriguing, the measurement of TAC
only gives an overview of antioxidant status. Future studies are needed to elucidate the
relationship between specific antioxidant enzymes, such as glutathione peroxidase, MnSOD

Clin Sci (Lond). Author manuscript; available in PMC 2011 August 24.

WITKOWSKI et al.

Page 8

and catalase, and EPCs as well as the signalling cascades involved with exercise training and
inactivity.
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Although HI participants predominantly performed lower-body (running) exercise training
for over 30 years, we observed significant differences in the peak reactive hyperaemic FBF
response and AUC1min compared with that of sedentary LO participants. Furthermore, with
cessation of exercise training for 10 days, we observed a decline in reactive hyperaemic FBF
response in the HI group, supporting a systemic effect of exercise on vascular function.
One limitation of our present study is the large degree of individual variability in our EPC
measurements. We believe that the individual variability is indicative of other factors that
may have been present but not measured in the current study. Our sample size precluded an
investigation of potential factors that may have been responsible for differences between
responders and non-responders to detraining. Although we did not find a significant
difference in resting CD34+/VEGFR2+ cells between HI and LO groups, our LO group was
healthy, which may make this group unique for their age. Further studies are needed to
elucidate the molecular mechanisms that underlie the relationship between dynamic changes
in EPCs, vascular function and oxidative stress.
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We utilized the reactive hyperaemic FBF response to measure vascular function. In addition
to NO, other factors such as adenosine, mechanical and neurogenic factors may also play a
role in the vasodilatory response to reactive hyperaemia. However, studies utilizing NOS
(NO synthase) agonists or blockade (NG-monomethyl-l-arginine) have shown that
endothelium-derived NO plays a significant role in the reactive hyperaemic vasodilatory
response [45,46], and there is a strong correlation between peak reactive hyperaemic FBF
and peak vasodilation via acetylcholine (r = 0.89 [47]).
In conclusion, circulating CD34+/VEGFR2+ cells at rest appear to be associated with
dynamic changes in reactive hyperaemic FBF response with short-term detraining in men.
Furthermore, changes in circulating CD34+/VEGFR2+ cells that occur with short-term
detraining may be influenced by oxidative stress. Our findings, in concert with the available
literature on exercise and progenitor cells, support EPCs as a potentially important
mechanism by which regular exercise maintains healthy vascular function.
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Abbreviations
AUC

area under the curve

BMI

body mass index

BP

blood pressure

CAD

coronary artery disease

CFU-EC

colony-forming unit-endothelial cell

CHD

coronary heart disease
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CV

coefficient of variation

CVD

cardiovascular disease

EPC

endothelial progenitor cell

FBF

forearm blood flow

FVR

forearm vascular resistance

β-gal

β-galactosidase

HDL

high-density lipoprotein

HI

highly active with a long-term physical activity history

HPC

haemapoietic progenitor cell

LDL

low-density lipoprotein

LO

low-active sedentary but healthy

MnSOD

manganese superoxide

NOx

nitrate/nitrite

OxLDL

oxidized LDL

TAC

total antioxidant capacity

VEGF

vascular endothelial growth factor

VEGFR

VEGF receptor

VLDL

very-low-density lipoprotein

V̇O2

oxygen consumption

V̇O2max

maximal V̇O2
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Figure 1. Reactive hyperaemic response in the HI group before and after detraining and the LO
control subjects

Values are means ± S.E.M. Baseline and detrained represent the results for the ten men in
the HI group who underwent 10 days of detraining. LO group, n = 11. *P < 0.05 for the HI
baseline group compared with the LO group; †P < 0.05 for the HI detrained group
compared with the LO group.
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Figure 2. CD34+ cells before and after 10 days of detraining

*P < 0.05 compared with the HI baseline group.

NIH-PA Author Manuscript
NIH-PA Author Manuscript
Clin Sci (Lond). Author manuscript; available in PMC 2011 August 24.

WITKOWSKI et al.

Page 15

NIH-PA Author Manuscript
Figure 3. CD34+/VEGFR2+ cells before and after 10 days of detraining
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Values are means ± S.E.M. Because data for CD34+/VEGFR2+ cell number were not
normally distributed, data were analysed using the non-parametric Wilcoxon signed rank
test.
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Table 1

Descriptive data of the study populations

NIH-PA Author Manuscript

Group
Characteristic

LO (n = 11)

HI baseline (n = 12)

HI detrained (n = 10)

Age (years)

64 ± 2

62 ± 2

62 ± 2

Height (m)

1.76 ± 0.02

1.78 ± 0.03

1.75 ± 0.02

Weight (kg)

73.0 ± 2.4

70.1 ± 2.9

67.6 ± 2.3

(kg/m2)

23.6 ± 0.7

22.0 ± 0.8

22.1 ± 0.7

Body fat (%)

23.5 ± 1.8

18.0 ± 1.3*

18.1 ± 1.1†

SBP (mmHg)

129 ± 3

122 ± 3

114 ± 3

DBP (mmHg)

85 ± 2

79 ± 2*

77 ± 2†

Glucose (mg/dl)

99 (91–122)

94.5 (83–104)

–

Cholesterol (mg/dl)

194.2 ± 10.6

199.1 ± 8.9

–

Triacylglycerols (mg/dl)

103.0 ± 13.5

66.2 ± 8.4*

–

HDL-cholesterol (mg/dl)

51.0 ± 4.6

71.2 ± 3.3*

–

LDL-cholesterol (mg/dl)

122.5 ± 11.4

114.8 ± 8.4

–

VLDL-cholesterol (mg/dl)

20.6 ± 2.7

13.2 ± 1.7*

–

Total cholesterol/HDL-cholesterol

4.2 ± 0.5

2.9 ± 0.2*

–

Framingham 10-year CHD risk (%)

12.82 ± 2.2

7.67 ± 0.86*

–

V̇O2max (ml/kg of body weight)

28.1 ± 1.7

50.0 ± 1.9*

–

V̇O2max (litres/min)

2.07 ± 0.12

3.51 ± 0.17*

–

Days/week running

–

5 ± 0.4

Miles/week running

–

36 ± 3

Years exercising

–

32 ± 3

BMI

NIH-PA Author Manuscript

Values are means ± S.E.M. For data that were not normally distributed, medians (lowest value-highest value) are shown, and P values were
obtained from a-Mann–Whitney U test.
*

P ≤0.05 compared with the LO group;

†

P ≤0.05 compared with the HI baseline group. Owing to participant burden, not all parameters were measured following detraining.
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